An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.

An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.

Artesunate+amodiaquine (AS+AQ) and artemether-lumefantrine (AL) are now the most frequently recommended first line treatments for uncomplicated malaria in Africa. Artesunate+chlorproguanil-dapsone (AS+CD) was a potential alternative for treatment of uncomplicated malaria. A comparison of the efficac...

Full description

Bibliographic Details
Main Authors: Seth Owusu-Agyei, Kwaku Poku Asante, Ruth Owusu, Martin Adjuik, Stephen Amenga-Etego, David Kwame Dosoo, John Gyapong, Brian Greenwood, Daniel Chandramohan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-06-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2430614?pdf=render

Internet

http://europepmc.org/articles/PMC2430614?pdf=render

Similar Items